GGrantIndex
← Leaderboards

Dana Borden Lacy

Vanderbilt University

$9,960,545
Attributed
$10,683,084
Total exposure
16
Grants
15
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.1M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,393,225 · 16
VA$0 · 1

By mechanism

R01$5,866,641 · 3
U19$5,820,916 · 5
R37$2,592,810 · 1
T32$1,083,809 · 1
R13$19,500 · 2
P41$9,549 · 4

Top collaborators

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Structure

Research focus

StructureToxinCellsProteinsVirulence FactorsClostridium DifficileReproduction SporesPseudomembranous ColitisDiarrheaInfectionResponseProgramsPathogenesisAnaerobic BacteriaComplexMediatingColonDesignToxic MegacolonCessation Of LifeAntibioticsUnited StatesFamilyBinding

Grant awards (49)

Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines$1,570,047
U19 · FY2025 · AI · contact PI
Molecular Biophysics Training Grant at Vanderbilt$534,450
T32 · FY2025 · GM
Structural Mechanisms of Clostridioides difficile pathogenesis$518,562
R37 · FY2025 · AI · contact PI
Project 1: Mucosal toxin subunit immunization as a strategy for C. difficile vaccine development$419,638
U19 · FY2025 · AI · contact PI
Administrative Core$64,721
U19 · FY2025 · AI · contact PI
The role of toxins in Clostridioides difficile infection pathogenesis.$0
I01 · FY2025 · VA · contact PI
Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines$1,570,047
U19 · FY2024 · AI · contact PI
Molecular Biophysics Training Grant at Vanderbilt$549,359
T32 · FY2024 · GM
Structural Mechanisms of Clostridioides difficile pathogenesis$518,562
R37 · FY2024 · AI · contact PI
Project 1: Mucosal toxin subunit immunization as a strategy for C. difficile vaccine development$255,771
U19 · FY2024 · AI · contact PI
Administrative Core$62,148
U19 · FY2024 · AI · contact PI
The role of toxins in Clostridioides difficile infection pathogenesis.$0
I01 · FY2024 · VA · contact PI
Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines$1,570,047
U19 · FY2023 · AI · contact PI
Structural Mechanisms of Clostridioides difficile pathogenesis$518,562
R37 · FY2023 · AI · contact PI
Project 1: Mucosal toxin subunit immunization as a strategy for C. difficile vaccine development$256,231
U19 · FY2023 · AI · contact PI
Administrative Core$52,266
U19 · FY2023 · AI · contact PI
The role of toxins in Clostridium difficile infection pathogenesis$0
I01 · FY2023 · VA · contact PI
Structural Mechanisms of Clostridioides difficile pathogenesis$518,562
R37 · FY2022 · AI · contact PI
The role of toxins in Clostridium difficile infection pathogenesis$0
I01 · FY2022 · VA · contact PI
Structural Mechanisms of Clostridioides difficile pathogenesis$518,562
R37 · FY2021 · AI · contact PI
12th International Conference on the Molecular Biology and Pathogenesis of Clostridia (Clostpath 12)$11,000
R13 · FY2021 · AI · contact PI
The role of toxins in Clostridium difficile infection pathogenesis$0
I01 · FY2021 · VA · contact PI
Structural mechanisms of Clostridium difficile pathogenesis$394,304
R01 · FY2020 · AI · contact PI
The role of toxins in Clostridium difficile infection pathogenesis$0
I01 · FY2020 · VA · contact PI
Structural mechanisms of Clostridium difficile pathogenesis$394,304
R01 · FY2019 · AI · contact PI
The 11th International Conference on the Molecular Biology and Pathogenesis of Clostridia (Clostpath 11)$8,500
R13 · FY2019 · AI · contact PI
Pre-clinical evaluation of Clostridium difficile toxin inhibitors$0
I01 · FY2019 · VA · contact PI
Structural mechanisms of Clostridium difficile pathogenesis$394,304
R01 · FY2018 · AI · contact PI
Pre-clinical evaluation of Clostridium difficile toxin inhibitors$0
I01 · FY2018 · VA · contact PI
Structural mechanisms of Clostridium difficile pathogenesis$394,304
R01 · FY2017 · AI · contact PI
Pre-clinical evaluation of Clostridium difficile toxin inhibitors$0
I01 · FY2017 · VA · contact PI
Structural mechanisms of Clostridium difficile pathogenesis$394,304
R01 · FY2016 · AI · contact PI
Pre-clinical evaluation of Clostridium difficile toxin inhibitors$0
I01 · FY2016 · VA · contact PI
Structural mechanisms of Clostridium difficile pathogenesis$388,865
R01 · FY2015 · AI · contact PI
Structural mechanisms of Clostridium difficile pathogenesis$388,898
R01 · FY2014 · AI · contact PI
Structural mechanisms of Clostridium difficile pathogenesis$365,595
R01 · FY2013 · AI · contact PI
Structural mechanisms of Clostridium difficile pathogenesis$388,962
R01 · FY2012 · AI · contact PI
Structural Mechanisms of Botulinum Neurotoxin Pathogenesis$300,891
R01 · FY2012 · AI · contact PI
Structural mechanisms of Clostridium difficile pathogenesis$388,579
R01 · FY2011 · AI · contact PI
Structural Mechanisms of Botulinum Neurotoxin Pathogenesis$300,891
R01 · FY2011 · AI · contact PI
Directed evolution of inhibitors of anthrax toxin$295,174
R01 · FY2011 · AI · contact PI
Structural Mechanisms of Botulinum Neurotoxin Pathogenesis$303,930
R01 · FY2010 · AI · contact PI
Structural Mechanisms of Botulinum Neurotoxin Pathogenesis$307,000
R01 · FY2009 · AI · contact PI
Directed evolution of inhibitors of anthrax toxin$159,336
R01 · FY2009 · AI · contact PI
CRYSTAL STRUCTURE OF THE HELICOBACTER PYLORI VACUOLATING TOXIN VACA$8,556
P41 · FY2009 · RR · contact PI
CRYSTAL STRUCTURE DETERMINATION OF H PYLORI VACA$213
P41 · FY2009 · RR · contact PI
Structural Mechanisms of Botulinum Neurotoxin Pathogenesis$307,000
R01 · FY2008 · AI · contact PI
CRYSTAL STRUCTURE DETERMINATION OF H PYLORI VACA$184
P41 · FY2008 · RR · contact PI
CRYSTAL STRUCTURE DETERMINATION OF H PYLORI VACA$596
P41 · FY2007 · RR · contact PI